World Hepatitis
Summit 2024

9 - 11 April - Lisbon, Portugal

The World Hepatitis Summit (WHS) is the only global hepatitis conference which is focussed on a multi-stakeholder, multi-sector public health approach which brings together diverse participants, from civil society to policy makers, private sector to academics, to make the dream of hepatitis elimination a reality.

WHS 2024 is organised by the World Hepatitis Alliance with the support of the Ministry of Health of Portugal.
Portugal

Countdown to the World Hepatitis Summit 2024!

Days
Hours
Minutes
Seconds

There are few diseases we can realistically dream of eliminating but hepatitis is one of them. Sustained funding, relentless advocacy, and visionary political leadership will be essential for realising that dream.

Dr Tedros Ghebreyesus, Director-General, World Health Organization (WHO), World Hepatitis Summit 2022, Opening session

WHS 2024 theme:

Integrate

Accelerate

Eliminate

Why attend?

If we go after [viral hepatitis] with the same zeal that the world went after smallpox elimination, we can do this.
Ms Helen Clark, Former Prime Minister of New Zealand, World Hepatitis Summit 2022, Opening session
Helen Clark

Who should attend?

WHS brings together all the stakeholders required to drive change.

Hepatitis and PWID/harm reduction 

 

11:35 – 11:40  

Chair: WHO – Intro and set the scene.  

 

11:40 – 11:55  

Co-chair:  EMCDDA – Monitoring viral hepatitis elimination among PWID in Europe. 

 

11:55 – 12:00 

ID 29: Ema Pos (not yet registered) 

Title: If the mountain won’t come to Mohammed: lessons from a decentralized Infectious Disease consultation. 

 

12:05 – 12:10  

ID 152: Brian Conway (Registered in person) 

Title: Community Pop-up Clinic: Cascade of Care and HCV Treatment of Vancouver’s inner-city PWID Populations.

 

12:10 – 12:15 

ID 212: Jasmine West (not yet registered) 

Title: From lived experience to lived expertise: a syndemic approach. 

 

12:15 – 12:20 

ID: 299 Mercy Nyakowa (Registered in person) 

Title: HCV and HBV prevalence and associated risk factors among people who inject drugs (PWIDs) in Kenya 

 

12:20 – 12:25 

ID: 133 Nalinikanta Rajkumar (Registered in person) 

Title: Rapid regimen of HBV vaccination: Does it work for high risk groups?  

 

12:25 – 12:30 

Q&A and closing remarks   

The role of decentralised and community-led services in accelerating progress towards elimination.

Role of harm reduction.